Share Price and Basic Stock Data
Last Updated: December 30, 2025, 5:01 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dolphin Medical Services Ltd operates in the Hospitals & Medical Services sector, with a current market capitalization of ₹4.33 Cr and a share price of ₹2.87. The company has faced challenges in revenue generation, with reported sales of ₹0.61 Cr for the fiscal year ending March 2023, showing a slight increase from ₹0.52 Cr in the previous year. However, sales have fluctuated quarterly, peaking at ₹0.25 Cr in September 2024 but dipping to ₹0.14 Cr by June 2025. This inconsistency highlights potential volatility in revenue streams. The company reported total sales of ₹0.73 Cr for the trailing twelve months (TTM), indicating a modest upward trajectory compared to historical figures. The revenue per share has also been low, with figures standing at ₹0.37 for March 2016, showcasing a long-term struggle to enhance operational performance. Overall, while there are signs of gradual improvement, the revenue trend remains a key area of concern for stakeholders.
Profitability and Efficiency Metrics
Dolphin Medical Services Ltd has struggled with profitability, as reflected in its negative net profit of ₹0.02 Cr for the year ending March 2023. The operating profit margin (OPM) stood at a meager 11.11%, indicating limited profitability relative to sales. Quarterly operating profits have been inconsistent, with a high of ₹0.02 Cr in June 2023 and a low of -₹0.08 Cr in March 2023. The company recorded a return on equity (ROE) of 30% and a return on capital employed (ROCE) of 18%, both of which are relatively favorable but may be misleading due to the overall negative net profit situation. The interest coverage ratio (ICR) stood at 5.76x, suggesting that the company can comfortably cover its interest obligations. However, the cash conversion cycle (CCC) of 30.42 days remains an area for improvement, indicating potential inefficiencies in managing working capital. These metrics collectively underscore the company’s challenges in achieving sustainable profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Dolphin Medical Services Ltd reflects a concerning financial position, with total liabilities reported at ₹12.21 Cr and reserves declining to -₹5.02 Cr as of September 2025. The company has minimal borrowings of ₹0.83 Cr, which indicates a conservative debt approach. However, the negative reserves point to a significant accumulated loss over the years, raising concerns about the company’s financial health. The price-to-book value (P/BV) ratio is notably low at 0.13x, suggesting that the stock is undervalued relative to its book value, but this may also reflect market apprehension regarding its operational viability. The current ratio stands at a robust 29.59, indicating excellent liquidity, but this figure may be misleading given the company’s historical performance. Financial ratios such as the return on assets (ROA) remain negative, highlighting ongoing inefficiencies despite the apparent liquidity strength.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dolphin Medical Services Ltd shows a stable structure, with promoters holding 26.44% and the public holding 73.57% as of September 2025. The number of shareholders has seen a slight increase, reaching 9,349, which may indicate growing investor interest despite the company’s challenges. The high public shareholding suggests a diverse investor base, which can be a positive indicator of market confidence. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could reflect hesitance from larger investors regarding the company’s long-term prospects. The stable promoter holding may provide some reassurance to retail investors, but the overall sentiment is tempered by the company’s ongoing financial struggles. This mix of stable ownership and lack of institutional support presents a nuanced picture of investor confidence in Dolphin Medical Services Ltd.
Outlook, Risks, and Final Insight
The outlook for Dolphin Medical Services Ltd remains cautiously optimistic, contingent on its ability to stabilize revenue and improve profitability metrics. Key strengths include a low debt level, which provides operational flexibility, and a high current ratio, reflecting strong liquidity. However, significant risks persist, including negative reserves and fluctuating sales figures, which could hinder growth and investor confidence. The company’s ongoing challenges in achieving consistent profitability and managing operational efficiency pose additional risks. Should the company successfully implement measures to enhance revenue generation and control costs, it could see an improvement in its financial standing. Conversely, failure to address these issues may lead to further declines in shareholder value. The path forward will require strategic initiatives focused on operational excellence and market positioning to regain investor trust.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 50.2 Cr. | 150 | 187/120 | 10.2 | 117 | 2.34 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 26.5 Cr. | 25.2 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 8.67 Cr. | 8.38 | 20.8/7.08 | 96.3 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 110 Cr. | 58.5 | 98.7/55.2 | 24.2 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.5 Cr. | 3.79 | 7.29/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,049.64 Cr | 692.34 | 93.15 | 93.18 | 0.32% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.16 | 0.22 | 0.08 | 0.15 | 0.18 | 0.20 | 0.14 | 0.14 | 0.25 | 0.24 | 0.14 | 0.17 | 0.18 |
| Expenses | 0.17 | 0.20 | 0.16 | 0.13 | 0.17 | 0.20 | 0.27 | 0.13 | 0.23 | 0.23 | 0.19 | 0.14 | 0.16 |
| Operating Profit | -0.01 | 0.02 | -0.08 | 0.02 | 0.01 | 0.00 | -0.13 | 0.01 | 0.02 | 0.01 | -0.05 | 0.03 | 0.02 |
| OPM % | -6.25% | 9.09% | -100.00% | 13.33% | 5.56% | 0.00% | -92.86% | 7.14% | 8.00% | 4.17% | -35.71% | 17.65% | 11.11% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.03 |
| Profit before tax | -0.02 | 0.01 | -0.09 | 0.02 | 0.01 | 0.00 | -0.13 | 0.01 | 0.02 | 0.01 | -0.07 | 0.03 | 0.00 |
| Tax % | 0.00% | 0.00% | 11.11% | 0.00% | 0.00% | 7.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | -0.01 | 0.01 | -0.10 | 0.01 | 0.01 | 0.00 | -0.13 | 0.01 | 0.02 | 0.01 | -0.07 | 0.03 | 0.01 |
| EPS in Rs | -0.01 | 0.01 | -0.07 | 0.01 | 0.01 | 0.00 | -0.09 | 0.01 | 0.01 | 0.01 | -0.05 | 0.02 | 0.01 |
Last Updated: December 27, 2025, 5:36 am
Below is a detailed analysis of the quarterly data for Dolphin Medical Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Jun 2025) to 0.18 Cr., marking an increase of 0.01 Cr..
- For Expenses, as of Sep 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Jun 2025) to 0.16 Cr., marking an increase of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For OPM %, as of Sep 2025, the value is 11.11%. The value appears to be declining and may need further review. It has decreased from 17.65% (Jun 2025) to 11.11%, marking a decrease of 6.54%.
- For Other Income, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Jun 2025) to 0.03 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.02 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.02 (Jun 2025) to 0.01, marking a decrease of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.96 | 0.36 | 0.57 | 0.35 | 0.15 | 0.06 | 0.18 | 0.47 | 0.52 | 0.61 | 0.68 | 0.78 | 0.73 |
| Expenses | 1.06 | 0.39 | 0.39 | 0.33 | 0.23 | 0.20 | 0.52 | 6.24 | 0.66 | 0.69 | 0.76 | 0.78 | 0.72 |
| Operating Profit | -0.10 | -0.03 | 0.18 | 0.02 | -0.08 | -0.14 | -0.34 | -5.77 | -0.14 | -0.08 | -0.08 | 0.00 | 0.01 |
| OPM % | -10.42% | -8.33% | 31.58% | 5.71% | -53.33% | -233.33% | -188.89% | -1,227.66% | -26.92% | -13.11% | -11.76% | 0.00% | 1.37% |
| Other Income | 0.00 | 0.01 | 0.15 | 0.02 | 0.09 | -0.63 | 0.05 | 5.55 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Interest | 0.05 | 0.05 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.71 | 0.52 | 0.34 | 0.33 | 0.33 | 0.24 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.08 |
| Profit before tax | -0.86 | -0.59 | -0.07 | -0.30 | -0.33 | -1.02 | -0.36 | -0.29 | -0.17 | -0.11 | -0.10 | -0.03 | -0.03 |
| Tax % | 0.00% | -3.39% | -28.57% | -10.00% | -12.12% | -1.96% | 5.56% | 6.90% | 5.88% | 9.09% | 10.00% | 0.00% | |
| Net Profit | -0.86 | -0.57 | -0.05 | -0.27 | -0.30 | -1.01 | -0.39 | -0.31 | -0.19 | -0.12 | -0.10 | -0.03 | -0.02 |
| EPS in Rs | -0.57 | -0.38 | -0.03 | -0.18 | -0.20 | -0.67 | -0.26 | -0.21 | -0.13 | -0.08 | -0.07 | -0.02 | -0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.72% | 91.23% | -440.00% | -11.11% | -236.67% | 61.39% | 20.51% | 38.71% | 36.84% | 16.67% | 70.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 57.51% | -531.23% | 428.89% | -225.56% | 298.05% | -40.87% | 18.20% | -1.87% | -20.18% | 53.33% |
Dolphin Medical Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 34% |
| 3 Years: | 14% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 23% |
| TTM: | 91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 6% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves | -1.72 | -2.30 | -2.34 | -2.61 | -2.91 | -3.91 | -4.30 | -4.61 | -4.80 | -4.92 | -5.03 | -5.06 | -5.02 |
| Borrowings | 8.10 | 8.05 | 8.16 | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 | 0.80 | 0.87 | 0.83 |
| Other Liabilities | 0.75 | 0.74 | 0.67 | 0.65 | 0.61 | 0.58 | 0.71 | 1.23 | 1.26 | 1.23 | 1.27 | 1.17 | 1.30 |
| Total Liabilities | 22.23 | 21.59 | 21.59 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.21 |
| Fixed Assets | 11.23 | 14.50 | 10.36 | 10.03 | 9.70 | 6.79 | 6.74 | 3.00 | 2.94 | 2.87 | 2.83 | 2.76 | 6.67 |
| CWIP | 5.93 | 2.14 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 0.31 |
| Investments | 0.52 | 0.52 | 0.52 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Other Assets | 4.55 | 4.43 | 4.78 | 4.98 | 4.97 | 4.86 | 4.80 | 4.83 | 4.80 | 4.80 | 4.81 | 4.82 | 4.82 |
| Total Assets | 22.23 | 21.59 | 21.59 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.21 |
Below is a detailed analysis of the balance sheet data for Dolphin Medical Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.10 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.10 Cr..
- For Reserves, as of Sep 2025, the value is -5.02 Cr.. The value appears to be improving (becoming less negative). It has improved from -5.06 Cr. (Mar 2025) to -5.02 Cr., marking an improvement of 0.04 Cr..
- For Borrowings, as of Sep 2025, the value is 0.83 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 0.87 Cr. (Mar 2025) to 0.83 Cr., marking a decrease of 0.04 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.17 Cr. (Mar 2025) to 1.30 Cr., marking an increase of 0.13 Cr..
- For Total Liabilities, as of Sep 2025, the value is 12.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.08 Cr. (Mar 2025) to 12.21 Cr., marking an increase of 0.13 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.67 Cr.. The value appears strong and on an upward trend. It has increased from 2.76 Cr. (Mar 2025) to 6.67 Cr., marking an increase of 3.91 Cr..
- For CWIP, as of Sep 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 4.09 Cr. (Mar 2025) to 0.31 Cr., marking a decrease of 3.78 Cr..
- For Investments, as of Sep 2025, the value is 0.41 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.41 Cr..
- For Other Assets, as of Sep 2025, the value is 4.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.82 Cr..
- For Total Assets, as of Sep 2025, the value is 12.21 Cr.. The value appears strong and on an upward trend. It has increased from 12.08 Cr. (Mar 2025) to 12.21 Cr., marking an increase of 0.13 Cr..
However, the Borrowings (0.83 Cr.) are higher than the Reserves (-5.02 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.20 | -8.08 | -7.98 | -8.19 | -8.29 | -6.36 | -6.71 | -6.38 | -0.82 | -0.84 | -0.88 | -0.87 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 36.50 | 36.50 | 21.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.18 | 30.42 |
| Days Payable | 12.17 | 73.00 | 0.00 | 0.00 | 0.00 | |||||||
| Cash Conversion Cycle | 24.33 | -36.50 | 21.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.18 | 30.42 |
| Working Capital Days | 589.32 | 1,449.86 | 1,171.84 | 2,106.57 | 4,891.00 | 11,619.17 | 3,629.72 | 986.28 | 898.46 | 771.89 | 687.06 | 645.77 |
| ROCE % | -3.69% | -2.55% | -0.05% | -0.96% | -1.56% | -1.69% | -2.02% | -1.98% | -1.45% | -0.91% | -0.83% | -0.18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.03 | -0.38 | -0.57 | -1.31 | -0.99 |
| Diluted EPS (Rs.) | -0.03 | -0.38 | -0.57 | -1.31 | -0.99 |
| Cash EPS (Rs.) | 0.19 | -0.03 | -0.09 | -0.88 | -0.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 8.50 | 8.53 | 8.91 | 9.47 | 10.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.50 | 8.53 | 8.91 | 9.47 | 10.78 |
| Revenue From Operations / Share (Rs.) | 0.37 | 0.24 | 0.63 | 0.75 | 2.49 |
| PBDIT / Share (Rs.) | 0.21 | -0.02 | -0.06 | -0.39 | 0.25 |
| PBIT / Share (Rs.) | -0.01 | -0.36 | -0.53 | -0.82 | -0.17 |
| PBT / Share (Rs.) | -0.04 | -0.39 | -0.57 | -1.29 | -0.95 |
| Net Profit / Share (Rs.) | -0.03 | -0.38 | -0.57 | -1.31 | -0.98 |
| NP After MI And SOA / Share (Rs.) | -0.03 | -0.38 | -0.57 | -1.31 | -0.98 |
| PBDIT Margin (%) | 56.85 | -9.66 | -10.55 | -52.32 | 10.07 |
| PBIT Margin (%) | -2.35 | -146.84 | -85.02 | -108.98 | -7.09 |
| PBT Margin (%) | -12.23 | -156.99 | -89.80 | -170.48 | -38.47 |
| Net Profit Margin (%) | -8.16 | -152.48 | -90.22 | -173.28 | -39.61 |
| NP After MI And SOA Margin (%) | -8.16 | -152.48 | -90.22 | -173.28 | -39.61 |
| Return on Networth / Equity (%) | -0.36 | -4.48 | -6.46 | -13.88 | -9.18 |
| Return on Capital Employeed (%) | -0.06 | -2.56 | -3.67 | -5.36 | -1.08 |
| Return On Assets (%) | -0.21 | -2.65 | -3.87 | -8.49 | -6.03 |
| Long Term Debt / Equity (X) | 0.63 | 0.62 | 0.60 | 0.57 | 0.47 |
| Total Debt / Equity (X) | 0.63 | 0.62 | 0.60 | 0.57 | 0.47 |
| Asset Turnover Ratio (%) | 0.02 | 0.01 | 0.04 | 0.04 | 0.14 |
| Current Ratio (X) | 29.59 | 15.97 | 17.40 | 17.36 | 17.80 |
| Quick Ratio (X) | 29.46 | 15.89 | 17.10 | 17.01 | 17.49 |
| Interest Coverage Ratio (X) | 5.76 | -0.95 | -2.21 | -0.85 | 0.32 |
| Interest Coverage Ratio (Post Tax) (X) | 0.17 | -14.03 | -17.86 | -1.82 | -0.26 |
| Enterprise Value (Cr.) | 10.00 | 10.11 | 9.76 | 9.95 | 10.69 |
| EV / Net Operating Revenue (X) | 17.63 | 26.84 | 10.18 | 8.72 | 2.84 |
| EV / EBITDA (X) | 31.01 | -277.52 | -96.45 | -16.66 | 28.21 |
| MarketCap / Net Operating Revenue (X) | 3.12 | 5.29 | 1.67 | 1.46 | 0.78 |
| Price / BV (X) | 0.13 | 0.15 | 0.11 | 0.11 | 0.18 |
| Price / Net Operating Revenue (X) | 3.12 | 5.30 | 1.67 | 1.46 | 0.78 |
| EarningsYield | -0.02 | -0.28 | -0.53 | -1.19 | -0.50 |
After reviewing the key financial ratios for Dolphin Medical Services Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is -0.03. This value is below the healthy minimum of 5. It has increased from -0.38 (Mar 15) to -0.03, marking an increase of 0.35.
- For Diluted EPS (Rs.), as of Mar 16, the value is -0.03. This value is below the healthy minimum of 5. It has increased from -0.38 (Mar 15) to -0.03, marking an increase of 0.35.
- For Cash EPS (Rs.), as of Mar 16, the value is 0.19. This value is below the healthy minimum of 3. It has increased from -0.03 (Mar 15) to 0.19, marking an increase of 0.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 8.50. It has decreased from 8.53 (Mar 15) to 8.50, marking a decrease of 0.03.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 8.50. It has decreased from 8.53 (Mar 15) to 8.50, marking a decrease of 0.03.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 0.37. It has increased from 0.24 (Mar 15) to 0.37, marking an increase of 0.13.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 0.21. This value is below the healthy minimum of 2. It has increased from -0.02 (Mar 15) to 0.21, marking an increase of 0.23.
- For PBIT / Share (Rs.), as of Mar 16, the value is -0.01. This value is below the healthy minimum of 0. It has increased from -0.36 (Mar 15) to -0.01, marking an increase of 0.35.
- For PBT / Share (Rs.), as of Mar 16, the value is -0.04. This value is below the healthy minimum of 0. It has increased from -0.39 (Mar 15) to -0.04, marking an increase of 0.35.
- For Net Profit / Share (Rs.), as of Mar 16, the value is -0.03. This value is below the healthy minimum of 2. It has increased from -0.38 (Mar 15) to -0.03, marking an increase of 0.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -0.03. This value is below the healthy minimum of 2. It has increased from -0.38 (Mar 15) to -0.03, marking an increase of 0.35.
- For PBDIT Margin (%), as of Mar 16, the value is 56.85. This value is within the healthy range. It has increased from -9.66 (Mar 15) to 56.85, marking an increase of 66.51.
- For PBIT Margin (%), as of Mar 16, the value is -2.35. This value is below the healthy minimum of 10. It has increased from -146.84 (Mar 15) to -2.35, marking an increase of 144.49.
- For PBT Margin (%), as of Mar 16, the value is -12.23. This value is below the healthy minimum of 10. It has increased from -156.99 (Mar 15) to -12.23, marking an increase of 144.76.
- For Net Profit Margin (%), as of Mar 16, the value is -8.16. This value is below the healthy minimum of 5. It has increased from -152.48 (Mar 15) to -8.16, marking an increase of 144.32.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is -8.16. This value is below the healthy minimum of 8. It has increased from -152.48 (Mar 15) to -8.16, marking an increase of 144.32.
- For Return on Networth / Equity (%), as of Mar 16, the value is -0.36. This value is below the healthy minimum of 15. It has increased from -4.48 (Mar 15) to -0.36, marking an increase of 4.12.
- For Return on Capital Employeed (%), as of Mar 16, the value is -0.06. This value is below the healthy minimum of 10. It has increased from -2.56 (Mar 15) to -0.06, marking an increase of 2.50.
- For Return On Assets (%), as of Mar 16, the value is -0.21. This value is below the healthy minimum of 5. It has increased from -2.65 (Mar 15) to -0.21, marking an increase of 2.44.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.63. This value is within the healthy range. It has increased from 0.62 (Mar 15) to 0.63, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.63. This value is within the healthy range. It has increased from 0.62 (Mar 15) to 0.63, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.02. It has increased from 0.01 (Mar 15) to 0.02, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 29.59. This value exceeds the healthy maximum of 3. It has increased from 15.97 (Mar 15) to 29.59, marking an increase of 13.62.
- For Quick Ratio (X), as of Mar 16, the value is 29.46. This value exceeds the healthy maximum of 2. It has increased from 15.89 (Mar 15) to 29.46, marking an increase of 13.57.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 5.76. This value is within the healthy range. It has increased from -0.95 (Mar 15) to 5.76, marking an increase of 6.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 0.17. This value is below the healthy minimum of 3. It has increased from -14.03 (Mar 15) to 0.17, marking an increase of 14.20.
- For Enterprise Value (Cr.), as of Mar 16, the value is 10.00. It has decreased from 10.11 (Mar 15) to 10.00, marking a decrease of 0.11.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 17.63. This value exceeds the healthy maximum of 3. It has decreased from 26.84 (Mar 15) to 17.63, marking a decrease of 9.21.
- For EV / EBITDA (X), as of Mar 16, the value is 31.01. This value exceeds the healthy maximum of 15. It has increased from -277.52 (Mar 15) to 31.01, marking an increase of 308.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 3.12. This value exceeds the healthy maximum of 3. It has decreased from 5.29 (Mar 15) to 3.12, marking a decrease of 2.17.
- For Price / BV (X), as of Mar 16, the value is 0.13. This value is below the healthy minimum of 1. It has decreased from 0.15 (Mar 15) to 0.13, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 3.12. This value exceeds the healthy maximum of 3. It has decreased from 5.30 (Mar 15) to 3.12, marking a decrease of 2.18.
- For EarningsYield, as of Mar 16, the value is -0.02. This value is below the healthy minimum of 5. It has increased from -0.28 (Mar 15) to -0.02, marking an increase of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dolphin Medical Services Ltd:
- Net Profit Margin: -8.16%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -0.06% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.36% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 29.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 93.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.63
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.16%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | No.417, Sanali Heavens, Ameerpet, Hyderabad Telangana 500073 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. G V Mohan Prasad | Managing Director & CEO |
| Dr. M Lakshmi Sudha | WholeTime Director & CFO |
| Mr. Nanapaneni Buddha Sagar | Director |
| Mr. Narendra Seena Karkera | Independent Director |
| Mr. Vinay Vishnuraj Nayak | Independent Director |
FAQ
What is the intrinsic value of Dolphin Medical Services Ltd?
Dolphin Medical Services Ltd's intrinsic value (as of 31 December 2025) is ₹0.25 which is 91.29% lower the current market price of ₹2.87, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹4.33 Cr. market cap, FY2025-2026 high/low of ₹2.99/1.98, reserves of ₹-5.02 Cr, and liabilities of ₹12.21 Cr.
What is the Market Cap of Dolphin Medical Services Ltd?
The Market Cap of Dolphin Medical Services Ltd is 4.33 Cr..
What is the current Stock Price of Dolphin Medical Services Ltd as on 31 December 2025?
The current stock price of Dolphin Medical Services Ltd as on 31 December 2025 is ₹2.87.
What is the High / Low of Dolphin Medical Services Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dolphin Medical Services Ltd stocks is ₹2.99/1.98.
What is the Stock P/E of Dolphin Medical Services Ltd?
The Stock P/E of Dolphin Medical Services Ltd is .
What is the Book Value of Dolphin Medical Services Ltd?
The Book Value of Dolphin Medical Services Ltd is 6.68.
What is the Dividend Yield of Dolphin Medical Services Ltd?
The Dividend Yield of Dolphin Medical Services Ltd is 0.00 %.
What is the ROCE of Dolphin Medical Services Ltd?
The ROCE of Dolphin Medical Services Ltd is 0.18 %.
What is the ROE of Dolphin Medical Services Ltd?
The ROE of Dolphin Medical Services Ltd is 0.30 %.
What is the Face Value of Dolphin Medical Services Ltd?
The Face Value of Dolphin Medical Services Ltd is 10.0.